Amgen, Inc. 2026-07-01 Health serious FDA
Health · FDA · Recall #FDA-D-0612-2026
Corlanor (ivabradine) tablets, 5 mg, packaged in a) 14 tablets bottles (NDC… Recall
Issued July 1, 2026 · Amgen, Inc.
In July 2026, Amgen, Inc. recalled the Corlanor (ivabradine) tablets, 5 mg, packaged in a) 14 tablets bottles (NDC…, a serious health recall reported by the FDA.
Compiled by Dana Whitfield, RecallCheckr
What this means for you
Presence of Foreign Substance.
What you should do
- 1 Stop using Corlanor (ivabradine) tablets, 5 mg, packaged in a) 14 tablets bottles (NDC… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Amgen, Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Amgen, Inc.
- Category
- Health
- Recall date
- July 1, 2026
- Units affected
- Not reported
- Sold at
- Nationwide within the United States
- Recall number
- FDA-D-0612-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Amgen, Inc. has 4 recalls in our database.
- We're tracking 3,673 Health recalls in our database.
- This is the 453rd Health recall we've logged in 2026.